Cogent Biosciences, Inc. COGT Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s free cash flow yield?
- Cogent Biosciences, Inc. (COGT) reported free cash flow yield of -4.6% in Q1 2026.
- How has Cogent Biosciences, Inc.'s free cash flow yield changed year-over-year?
- Cogent Biosciences, Inc.'s free cash flow yield increased by 86.0% year-over-year, from -32.7% to -4.6%.
- What is the long-term trend for Cogent Biosciences, Inc.'s free cash flow yield?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s free cash flow yield has grown at a -32.0% compound annual growth rate (CAGR), from -15.5% to -4.9%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.